1   She has symptoms of fatigue, achiness, and exertional dyspnea.

2         Most commonly reported symptoms were exertional dyspnea (78%) and fatigue (73%).

3 I] = 0.9-6.6%), a 1.6-fold increased odds of exertional dyspnea (95% CI = 1.3-1.9), a 1.5-fold increa

4 previously healthy soldiers with unexplained exertional dyspnea and diminished exercise tolerance aft

5 t children with asthma may falsely attribute exertional dyspnea and esophageal reflux to asthma, lead

6 ] age 70 +/- 12 years; 21 women, 9 men) with exertional dyspnea and negative exercise test results, a

7                      HF symptoms, especially exertional dyspnea, are common in ARVC/D; yet, classic l

8 ient selection, including drug treatment for exertional dyspnea (beta-blockers, verapamil, disopyrami

9 s with moderate to severe heart failure that exertional dyspnea can be alleviated by improving muscle

10 pacemakers were implanted in 9 patients with exertional dyspnea caused by HHCO.

11                                              Exertional dyspnea, chest pain, palpitations, and ankle

12                                              Exertional dyspnea disproportionate to pulmonary functio

13                                              Exertional dyspnea is a frequent limiting symptom in pat

14                              Amelioration of exertional dyspnea is achieved by other mechanisms, such

15                 After heart transplantation, exertional dyspnea is markedly diminished.

16    The most common clinical presentation was exertional dyspnea (n=17; 65%), whereas 8 (31%) patients

17 rial, 150 subjects (age 67 +/- 9 years) with exertional dyspnea (New York Heart Association functiona

18 ars of age) with stage C heart failure (HF) (exertional dyspnea, New York Heart Association functiona

19                                              Exertional dyspnea or chest pain, prior limitation from

20 with heart failure are frequently limited by exertional dyspnea that may be due to the increased work